Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 7420540, 6 pages
http://dx.doi.org/10.1155/2016/7420540
Research Article

ACE Gene I/D Polymorphism and Obesity in 1,574 Patients with Type 2 Diabetes Mellitus

1Center for Diabetic Systems Medicine, Guangxi Key Laboratory of Excellence, Guilin Medical University, Guilin 541004, China
2Institute of Basic Medical Sciences, Guilin Medical University, Guilin 541004, China
3Department of Immunology, Faculty of Basic Medicine, Guilin Medical University, Guilin 541004, China

Received 18 August 2016; Revised 14 November 2016; Accepted 4 December 2016

Academic Editor: Donald H. Chace

Copyright © 2016 Yan-Hong Pan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Okamoto, S. Kihara, N. Ouchi et al., “Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice,” Circulation, vol. 106, no. 22, pp. 2767–2770, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. B. H. Jones, M. K. Standridge, and N. Moustaid, “Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells,” Endocrinology, vol. 138, no. 4, pp. 1512–1519, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Rigat, C. Hubert, F. Alhenc-Gelas, F. Cambien, P. Corvol, and F. Soubrier, “An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels,” Journal of Clinical Investigation, vol. 86, no. 4, pp. 1343–1346, 1990. View at Publisher · View at Google Scholar · View at Scopus
  4. P. S. Leung and P.-O. Carlsson, “Pancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus,” Pancreas, vol. 30, no. 4, pp. 293–298, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. L. Mathai, N. Chen, L. Cornall, and R. S. Weisinger, “The role of angiotensin in obesity and metabolic disease,” Endocrine, Metabolic and Immune Disorders—Drug Targets, vol. 11, no. 3, pp. 198–205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Massiera, J. Seydoux, A. Geloen et al., “Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity,” Endocrinology, vol. 142, no. 12, pp. 5220–5225, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Kim, “Association of angiotensin-converting enzyme insertion/deletion polymorphism with obesity, cardiovascular risk factors and exercise-mediated changes in Korean women,” European Journal of Applied Physiology, vol. 105, no. 6, pp. 879–887, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Fernández-Llama, E. Poch, J. Oriola et al., “Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis,” Kidney International, vol. 53, no. 6, pp. 1743–1747, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Anuurad, K. Shiwaku, A. Nogi et al., “The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder japanese workers,” Journal of Occupational Health, vol. 45, no. 6, pp. 335–343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. American Diabetes Association, “Standards of Medical Care in Diabetes—2010,” Diabetes Care, vol. 33, S1, pp. S11–S61, 2010. View at Publisher · View at Google Scholar
  11. “Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies,” The Lancet, vol. 363, no. 9403, pp. 157–163, 2004. View at Publisher · View at Google Scholar
  12. R. G. Kathrotia, S. J. Paralikar, P. V. Rao, and E. R. Oommen, “Impact of different grades of body mass index on left ventricular structure and function,” Indian Journal of Physiology and Pharmacology, vol. 54, no. 2, pp. 149–156, 2010. View at Google Scholar · View at Scopus
  13. G. N. Thomas, B. Tomlinson, J. C. N. Chan, J. E. Sanderson, C. S. Cockram, and J. A. J. H. Critchley, “Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of the ACE insertion/deletion polymorphism with type 2 diabetes,” Diabetes Care, vol. 24, no. 2, pp. 356–361, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. P. W. Wilson, R. D. Abbott, R. J. Garrison, and W. P. Castelli, “Estimation of very-low-density lipoprotein cholesterol from data on triglyceride concentration in plasma,” Clinical Chemistry, vol. 27, no. 12, pp. 2008–2010, 1981. View at Google Scholar · View at Scopus
  15. E. J. Roccella, “Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from the national high blood pressure education program,” Pediatrics, vol. 98, no. 4, pp. 649–658, 1996. View at Google Scholar · View at Scopus
  16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, “Report of the expert committee on the diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 26, supplement 1, pp. S5–S20, 2003. View at Publisher · View at Google Scholar
  17. F. Cambien, O. Poirier, L. Lecerf et al., “Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction,” Nature, vol. 359, no. 6396, pp. 641–644, 1992. View at Publisher · View at Google Scholar · View at Scopus
  18. G. de Simone, R. B. Devereux, M. Chinali et al., “Risk factors for arterial hypertension in adults with initial optimal blood pressure: the Strong Heart Study,” Hypertension, vol. 47, no. 2, pp. 162–167, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. B. V. Howard, G. Ruotolo, and D. C. Robbins, “Obesity and dyslipidemia,” Endocrinology and Metabolism Clinics of North America, vol. 32, no. 4, pp. 855–867, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Lorenzo, M. Okoloise, K. Williams, M. P. Stern, and S. M. Haffner, “The metabolic syndrome as predictor of type 2 diabetes: the san antonio heart study,” Diabetes Care, vol. 26, no. 11, pp. 3153–3159, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. R.-N. Feng, C. Zhao, C. Wang et al., “BMI is strongly associated with hypertension, and waist circumference is strongly associated with type 2 diabetes and dyslipidemia, in Northern Chinese adults,” Journal of Epidemiology, vol. 22, no. 4, pp. 317–323, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. J. E. Hall, A. A. Da Silva, J. M. Do Carmo et al., “Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins,” Journal of Biological Chemistry, vol. 285, no. 23, pp. 17271–17276, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Narkiewicz, “Diagnosis and management of hypertension in obesity,” Obesity Reviews, vol. 7, no. 2, pp. 155–162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Mehri, S. Mahjoub, S. Hammami et al., “Renin-Angiotensin system polymorphisms in relation to hypertension status and obesity in a Tunisian population,” Molecular Biology Reports, vol. 39, no. 4, pp. 4059–4065, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Min, Y. J. Kim, H. Lee et al., “Is the association between ACE genes and blood pressure mediated by postnatal growth during the first 3 years?” Early Human Development, vol. 88, no. 6, pp. 425–429, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. C. Eisenmann, M. A. Sarzynski, K. Glenn, M. Rothschild, and K. A. Heelan, “ACE I/D genotype, adiposity, and blood pressure in children,” Cardiovascular Diabetology, vol. 8, article 14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Cooper, N. McFarlane-Anderson, F. I. Bennett et al., “ACE, angiotensinogen and obesity: a potential pathway leading to hypertension,” Journal of Human Hypertension, vol. 11, no. 2, pp. 107–111, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Passaro, E. Dalla Nora, C. Marcello et al., “PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome,” Cardiovascular Diabetology, vol. 10, article 112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Alsafar, A. Hassoun, S. Almazrouei et al., “Association of angiotensin converting enzyme insertion-deletion polymorphism with hypertension in emiratis with type 2 diabetes mellitus and its interaction with obesity status,” Disease Markers, vol. 2015, Article ID 536041, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus